Back to Search Start Over

Home care for heart failure: can caregiver education prevent hospital admissions? A randomized trial in primary care.

Authors :
Padula MS
D'Ambrosio GG
Tocci M
D'Amico R
Banchelli F
Angeli L
Scarpa M
Capelli O
Cricelli C
Boriani G
Source :
Journal of cardiovascular medicine (Hagerstown, Md.) [J Cardiovasc Med (Hagerstown)] 2019 Jan; Vol. 20 (1), pp. 30-38.
Publication Year :
2019

Abstract

Aim: To assess the feasibility and effectiveness of a low-complexity, low-cost model of caregiver education in primary care, targeted to reduce hospitalizations of heart failure patients.<br />Methods: A cluster-randomized, controlled, open trial was proposed to general practitioners, who were invited to identify patients with heart failure, exclusively managed at home and continuously attended by a caregiver. Participating general practitioners were then randomized to: usual treatment; caregiver education (educational session for recognizing early symptoms/signs of heart failure, with recording in a diary of a series of patient parameters, including body weight, blood pressure, heart rate). The patients were observed at baseline and during a 12-month follow-up.<br />Results: Three hundred and thirteen patients were enrolled (163 in the intervention, 150 in the usual care group), 63% women, mean age 85.3 ± 7.7 years. At the end of the 12-month follow-up, a trend towards a lower incidence of hospitalizations was observed in the intervention group (hazard ratio 0.73; 95% CI 0.53-1.01 P = 0.061). Subgroup analysis showed that for patients with persistent/permanent atrial fibrillation, age less than 90 years or Barthel score equal to or greater than 50 a significant lower hospital admission rate occurred in the intervention group (hazard ratio 0.63; 95% CI 0.39-0.99; P = 0.048, hazard ratio 0.66; 95% CI 0.45-0.97; P = 0.036 and hazard ratio 0.61; 95% CI 0.41-0.89; P = 0.011, respectively).<br />Conclusion: Caregivers training for early recognition of symptoms/signs of worsening heart failure may be effective in reducing hospitalizations, although the benefit was evident only in specific patient subgroups (with persistent/permanent atrial fibrillation, age <90 years or Barthel score ≥ 50), with only a positive trend in the whole cohort.<br />Trial Registration: ClinicalTrials.gov Identifier: NCT03389841.

Details

Language :
English
ISSN :
1558-2035
Volume :
20
Issue :
1
Database :
MEDLINE
Journal :
Journal of cardiovascular medicine (Hagerstown, Md.)
Publication Type :
Academic Journal
Accession number :
30394960
Full Text :
https://doi.org/10.2459/JCM.0000000000000722